A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder

By Pollack Mark   Mangano Richard   Entsuah Richard   Tzanis Evan   Simon Naomi  

Psychopharmacology, Vol. 194, Iss. 2, 2007-10 ,pp. : 233-242

Springer Publishing Company

Access to resources Recommend Favorite

5-HT 1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo

By Broocks A.   Meyer T.   Opitz M.   Bartmann U.   Hillmer-Vogel U.   George A.   Pekrun G.   Wedekind D.   Ruther E.   Bandelow B.  

European Neuropsychopharmacology, Vol. 13, Iss. 3, 2003-05 ,pp. : 153-164

Elsevier

Access to resources Recommend Favorite

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder

By Dunbar G.   Judge R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 361-362

Elsevier

Access to resources Recommend Favorite

Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects

By Cohrs Stefan   Pohlmann Kathrin   Guan Zhenghua   Jordan Wolfgang   Meier Andreas   Huether Gerald   Rüther Eckart   Rodenbeck Andrea  

Psychopharmacology, Vol. 174, Iss. 3, 2004-07 ,pp. : 414-420

Springer Publishing Company

Access to resources Recommend Favorite

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

By Askari Neda  

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 883-892

Adis International

Access to resources Recommend Favorite